Lucas D. Knewstub

Lucas Knewstub practices at Cayuga Medical Center in Ithaca, New York, part of Centralus Health.

Lucas Knewstub's NPI, 1083103642, was assigned on May 8, 2018. Lucas Knewstub graduated from New York College of Osteo Medicine of New York Institute of Technology in 2018. Lucas Knewstub holds New York license 308462.

Lucas Knewstub's primary practice is Cayuga Medical Center, at 101 Dates Drive, Ithaca, NY 14850 in Tompkins County. The practice phone is (607) 274-4401.

Lucas Knewstub's primary practice is Cayuga Medical Center in Ithaca, New York, part of Centralus Health. Lucas Knewstub is also affiliated with Schuyler Hospital. The medical group on file is Emergency Medicine Associates of Cayuga. Dmand AI also links Lucas Knewstub to 1 more hospital, 2 medical groups and 1 community health center, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Lucas Knewstub practices, 4 sites in all. Vendor and product names are available with a free account.

Emergency medicine is Lucas Knewstub's primary specialty in the NPI Registry, under taxonomy code 207P00000X. Lucas Knewstub is licensed in New York.

CMS data shows 510 Medicare services from Lucas Knewstub across 4 procedure codes in 2024, for 317 Medicare patients. Medicare paid $42,103 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 317 Medicare patients who saw Lucas Knewstub in 2024. The largest group is 75 to 84, with 101 patients. 75% of them have high blood pressure, and 70% have high cholesterol. 35% are also on Medicaid. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Lucas Knewstub's median patient age at 40, with 55% women.

In 2024, Lucas Knewstub wrote 114 Medicare Part D claims for 90 patients. 92% of them were for generic drugs. CMS names the drug for 51 of them, across 4 drugs with 11 or more claims each, at $371 in total drug cost. In 2023, CMS named 37 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Lucas Knewstub for performance year 2024, reported through an alternative payment model (APM). Lucas Knewstub accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Lucas Knewstub graduated from New York College of Osteo Medicine of New York Institute of Technology in 2018.